Trenbolone Acetate — Dosing, Cycles, Half-Life & Side Effects

Trenbolone Acetate is a 19-nortestosterone derivative with a half-life of 3 days (72h from IM depot; no human PK data - veterinary compound). CRITICAL WARNINGS: (1) 19-nor compound with RISK OF PERMANENT SUPPRESSION. (2) SIGNIFICANT MENTAL HEALTH EFFECTS including insomnia, night sweats, anxiety, paranoia, aggression, and mood instability. Some users report personality changes. (3) Cardiovascular stress is substantial. ADVANCED USERS ONLY who understand and accept these risks. Primary risks include strong HPTA suppression, prolonged 19-nor metabolite clearance affecting PCT timing. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

Quick Facts

Class19-nor
Half-life3 days (72h from IM depot; no human PK data - veterinary compound)
Detection window150 days
AromatizationNo
HepatotoxicityNone
Suppression10/10
17α-alkylatedNo
19-nor structureYes (extended metabolite clearance)
Administrationinjectable

Typical Dosing Ranges

Common dose range: 200-400mg/week (lower doses recommended to minimize side effects)

Cycle length: 6-8 weeks maximum (longer increases permanent suppression and side effect risk)

Time to steady state: ~15 days

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

PCT Requirements

  • This compound causes clinically meaningful HPTA suppression. Post-cycle therapy is recommended.
  • As a 19-nor, metabolites persist for weeks after last dose — PCT start should be delayed until apparent half-life clearance plus adequate wash-out (typically 4–6+ weeks post-last-injection for nandrolone; longer for trenbolone-dominant stacks).
  • Depot clearance estimate: ~15 days post-last-dose before SERM start (5 × apparent depot half-life of 72h).
  • Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
  • Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

  • SEVERE MENTAL HEALTH EFFECTS - insomnia, night sweats (especially at night), anxiety, paranoia, irritability, aggression ('Tren rage')
  • RISK OF PERMANENT HPTA SUPPRESSION - 19-nor metabolites persist
  • Cardiovascular strain - significant impact on lipids and blood pressure
  • Prolactin elevation - may require cabergoline
  • Reduced cardio capacity ('Tren cough', respiratory effects)
  • Libido effects - can go either way
  • Frequent injections required (short ester)
  • Extended recovery time - standard PCT often insufficient
  • Not compatible with alcohol - severe reaction

Known Interactions

  • Trenbolone Acetate + Clenbuterol

    majorcardiovascular

    Both significantly impact cardiovascular system. Trenbolone raises BP, clenbuterol stresses heart.

    Recommendation: Avoid combination. If used, monitor BP and heart rate closely.

    Monitor: Blood pressure, Heart rate, ECG

  • Trenbolone Acetate + T3 (Cytomel/Liothyronine)

    moderatecardiovascular

    T3 increases metabolism and heart rate while trenbolone affects cardiovascular health.

    Recommendation: Use lowest effective doses. Monitor vitals closely.

    Monitor: Heart rate, Blood pressure, TSH

  • Both are 19-nor compounds affecting prolactin and progesterone. Compounding effects on HPTA.

    Recommendation: Consider prolactin management (cabergoline/P5P). Recovery may be prolonged.

    Monitor: Prolactin, Progesterone, LH, FSH

  • Deca and trenbolone are both 19-nors with long-lasting HPTA suppression.

    Recommendation: Not recommended together. Choose one 19-nor per cycle.

    Monitor: Prolactin, LH, FSH, Recovery timeline

  • Tamoxifen may up-regulate progestin receptors when used with 19-nor compounds.

    Recommendation: Consider enclomiphene as alternative SERM for PCT after trenbolone cycles.

    Monitor: Progesterone, Prolactin, LH, FSH

Monitoring (Bloodwork & Vitals)

  • Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
  • Lipid panel (total cholesterol, HDL, LDL, triglycerides)
  • CBC (hemoglobin, hematocrit — watch for erythrocytosis)
  • Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
  • Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of Trenbolone Acetate?

Trenbolone Acetate has a half-life of approximately 3 days (72h from IM depot; no human PK data - veterinary compound). Clearance estimate: 72h × 5 = 360h = 15 days. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for Trenbolone Acetate?

Commonly reported ranges for Trenbolone Acetate: 200-400mg/week (lower doses recommended to minimize side effects). Cycle length: 6-8 weeks maximum (longer increases permanent suppression and side effect risk). These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does Trenbolone Acetate suppress natural testosterone?

Trenbolone Acetate causes severe suppression of the HPTA axis (score 10/10). Post-cycle therapy (PCT) is recommended after use. As a 19-nor compound, metabolites persist for weeks-to-months and shift PCT timing later than non-19-nor cycles.

Does Trenbolone Acetate aromatize to estrogen?

Aromatization profile: No. Minimal to no aromatization expected, so aromatase inhibitors are not typically indicated for this compound alone.

What is Trenbolone Acetate typically used for?

Trenbolone Acetate is commonly used for: ADVANCED USERS ONLY - not for beginners under any circumstances, Competition prep (by experienced users), Those who have assessed and accepted mental health risks. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Citations

  1. Veterinary/environmental extrapolation. 2015. PubMed (environmental fate study) — Half-life approximately 3 days (72 hours); primary metabolite 17a-trenbolone 5.1-9.5 days in cattle excreta. No human PK data exists.
  2. Liu et al.. 2025. Substance Use & Misuse — AAS meta-analysis: SBP +12.43 mmHg (95% CI: 9.59-15.26), LDL-C +9.12 mg/dL (95% CI: 6.75-11.49)
  3. Hartgens F, Kuipers H. 2004. Sports Medicine — 19-nor AAS class effect - trenbolone suppresses HPT axis comparably to nandrolone; ~100-300% more potent than testosterone at androgen receptor; supports suppressionScore 10/10
  4. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use Trenbolone Acetate. Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.

Skip to main content